Nabsys Raises an Additional $13M, Round Totals $38M
GoLocalProv Business Team
Nabsys Raises an Additional $13M, Round Totals $38M
The milestone increases throughput by more than 10x.
The company announced the initial raise of $25 million in the round in April
GET THE LATEST BREAKING NEWS HERE -- SIGN UP FOR GOLOCAL FREE DAILY EBLAST“This milestone is a significant advancement to throughput for the High-Definition Mapping Platform and enables complete mapping of whole human genomes at a commercially attractive price and turnaround time and superior resolution compared to current technologies,” said Barrett Bready, M.D., Nabsys founder and CEO.
Nabsys will offer this next-generation High-Definition Genome Mapping Platform through an early access program in the first half of 2023.
“Hitachi High-Tech’s expanded investment into Nabsys further demonstrates our long-standing interest in providing a solution for the analysis of human genomic structural variation. We are excited to see this advancement in throughput and progress towards the commercialization of this valuable platform,” said Tsuyoshi Ogino, general manager, Molecular Research & Diagnostic Division at Hitachi High-Tech America.
“Structural variants (SVs) account for the majority of genomic variation in the human genome and despite implications in disease research and diagnosis, SVs are largely ignored due to relatively high cost, high computational burden, and inadequate performance of current tools,” said Bready, “once commercial, users will be able to increase the frequency with which they analyze structural variation.”
Nabsys featured the newly updated whole genome mapping instrument last week at the American Society of Human Genetics annual meeting in Los Angeles, California.